# Epigallocatechin Gallate and Other Antural Compounds in HPV Infections

> **NCT06098456** · PHASE2 · COMPLETED · sponsor: **Centro di Ricerca Clinica Salentino** · enrollment: 178 (actual)

## Conditions studied

- Papilloma-induced Cervical Lesions

## Interventions

- **DRUG:** EGCG, FA, HA, B12

## Key facts

- **NCT ID:** NCT06098456
- **Lead sponsor:** Centro di Ricerca Clinica Salentino
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-01
- **Primary completion:** 2024-05-15
- **Final completion:** 2024-06-28
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2024-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06098456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06098456, "Epigallocatechin Gallate and Other Antural Compounds in HPV Infections". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06098456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*